Literature DB >> 12269543

Erythropoietin, anemia, and orthostatic hypotension: the evidence mounts.

Sunil V Rao, Jonathan S Stamler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12269543     DOI： 10.1007/s10286-002-0031-0

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  13 in total

Review 1.  Management of neurogenic orthostatic hypotension in patients with autonomic failure.

Authors:  Christoph Schroeder; Jens Jordan; Horacio Kaufmann
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

Review 2.  Current pharmacological management of hypotensive syndromes in the elderly.

Authors:  Kannayiram Alagiakrishnan
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

3.  Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia.

Authors:  Robert E Schmidt; Dongyan Feng; Qiuling Wang; Karen G Green; Lisa L Snipes; Michael Yamin; Michael Brines
Journal:  Exp Neurol       Date:  2011-08-18       Impact factor: 5.330

Review 4.  Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hypotension.

Authors:  Satish R Raj; Samuel T Coffin
Journal:  Prog Cardiovasc Dis       Date:  2013 Jan-Feb       Impact factor: 8.194

Review 5.  Current pharmacologic treatment for orthostatic hypotension.

Authors:  Roy Freeman
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

6.  Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.

Authors:  Robert E Schmidt; Karen G Green; Dongyan Feng; Denise A Dorsey; Curtis A Parvin; Jin-Moo Lee; Qinlgi Xiao; Michael Brines
Journal:  Exp Neurol       Date:  2007-10-29       Impact factor: 5.330

7.  Low iron storage and mild anemia in postural tachycardia syndrome in adolescents.

Authors:  Imad T Jarjour; Laila K Jarjour
Journal:  Clin Auton Res       Date:  2013-05-30       Impact factor: 4.435

8.  A novel protective effect of erythropoietin in the infarcted heart.

Authors:  Cyrus J Parsa; Akio Matsumoto; Jihee Kim; Ryan U Riel; Laura S Pascal; G Brant Walton; Richard B Thompson; Jason A Petrofski; Brian H Annex; Jonathan S Stamler; Walter J Koch
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

9.  Treatment options for autonomic neuropathies.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

10.  Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium.

Authors:  Emil Ruvinov; Orna Sharabani-Yosef; Arnon Nagler; Tom Einbinder; Micha S Feinberg; Radka Holbova; Amos Douvdevani; Jonathan Leor
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.